Ferium 1K Injection contains Ferric Carboxymaltose (50mg/ml), a parenteral iron preparation used to treat iron deficiency anemia, particularly in patients who cannot tolerate or absorb oral iron supplements effectively. This injectable formulation provides a rapid and efficient means of replenishing iron stores in the body by delivering iron directly into the bloodstream, facilitating the synthesis of hemoglobin and restoring normal red blood cell production. Ferium 1K Injection is commonly indicated for patients with chronic kidney disease, postpartum anemia, or those undergoing chemotherapy who experience iron deficiency. The administration of Ferric Carboxymaltose allows for larger doses of iron to be given in a single infusion, reducing the frequency of injections compared to traditional iron therapies. It is generally well tolerated, but potential side effects may include hypersensitivity reactions, hypotension, nausea, dizziness, and injection site reactions. Prior to administration, patients should be evaluated for iron overload conditions and monitored for allergic responses. Ferium 1K Injection should be used under medical supervision, with dosage tailored according to the severity of iron deficiency and patient-specific factors. This medication plays a crucial role in improving quality of life by correcting anemia and enhancing oxygen delivery to tissues.